Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Revenue

In the year 2025, Teyi Pharmaceutical Group Co.,Ltd had annual revenue of 924.53M CNY with 34.42% growth. Teyi Pharmaceutical Group Co.,Ltd had revenue of 232.68M in the quarter ending December 31, 2025, with 0.21% growth.

• Revenue: 924.53M
• Revenue Growth: +34.42%
• P/S Ratio: 5.37
• Revenue / Employee: 644.72K
• Employees: 1,434
• Market Cap: 4.96B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	924.53M	236.74M	34.42%
Dec 31, 2024	687.79M	-379.43M	-35.55%
Dec 31, 2023	1.07B	180.64M	20.38%
Dec 31, 2022	886.57M	128.41M	16.94%
Jan 1, 2022	758.16M	125.47M	19.83%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error